309 related articles for article (PubMed ID: 29126721)
21. Indazole- and indole-5-carboxamides: selective and reversible monoamine oxidase B inhibitors with subnanomolar potency.
Tzvetkov NT; Hinz S; Küppers P; Gastreich M; Müller CE
J Med Chem; 2014 Aug; 57(15):6679-703. PubMed ID: 24955776
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, biological investigation and molecular docking study of N-malonyl-1,2-dihydroisoquinoline derivatives as brain specific and shelf-stable MAO inhibitors.
Abd El-Gaber MK; Hassan HY; Mahfouz NM; Farag HH; Bekhit AA
Eur J Med Chem; 2015 Mar; 93():481-91. PubMed ID: 25732770
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, in vitro and in silico evaluation of new pyrrole derivatives as monoamine oxidase inhibitors.
Altintop MD; Sever B; Osmaniye D; Sağlık BN; Özdemir A
Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800082. PubMed ID: 29963739
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors.
Choi JW; Jang BK; Cho NC; Park JH; Yeon SK; Ju EJ; Lee YS; Han G; Pae AN; Kim DJ; Park KD
Bioorg Med Chem; 2015 Oct; 23(19):6486-96. PubMed ID: 26337020
[TBL] [Abstract][Full Text] [Related]
25. Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors.
Legoabe LJ; Petzer A; Petzer JP
Bioorg Chem; 2012 Dec; 45():1-11. PubMed ID: 23064123
[TBL] [Abstract][Full Text] [Related]
26. Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases.
Bonaiuto E; Milelli A; Cozza G; Tumiatti V; Marchetti C; Agostinelli E; Fimognari C; Hrelia P; Minarini A; Di Paolo ML
Eur J Med Chem; 2013; 70():88-101. PubMed ID: 24140951
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and Biological Evaluation of New Thiosemicarbazone Derivative Schiff Bases as Monoamine Oxidase Inhibitory Agents.
Çavuşoğlu BK; Sağlık BN; Osmaniye D; Levent S; Acar Çevik U; Karaduman AB; Özkay Y; Kaplancıklı ZA
Molecules; 2017 Dec; 23(1):. PubMed ID: 29283399
[TBL] [Abstract][Full Text] [Related]
28. Monoamine oxidase inhibitors: benzylidene-prop-2-ynyl-amines analogues.
Jia Z; Wei S; Zhu Q
Biol Pharm Bull; 2010; 33(4):725-8. PubMed ID: 20410615
[TBL] [Abstract][Full Text] [Related]
29. Potent inhibitions of monoamine oxidase A and B by acacetin and its 7-O-(6-O-malonylglucoside) derivative from Agastache rugosa.
Lee HW; Ryu HW; Baek SC; Kang MG; Park D; Han HY; An JH; Oh SR; Kim H
Int J Biol Macromol; 2017 Nov; 104(Pt A):547-553. PubMed ID: 28634060
[TBL] [Abstract][Full Text] [Related]
30. Syntheses and Evaluation of 2- or 3-(N-Cyclicamino)chromone Derivatives as Monoamine Oxidase Inhibitors.
Takao K; Sakatsume T; Kamauchi H; Sugita Y
Chem Pharm Bull (Tokyo); 2020; 68(11):1082-1089. PubMed ID: 33132375
[TBL] [Abstract][Full Text] [Related]
31. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, in vitro MAO-B inhibitory evaluation, and computational studies of some 6-nitrobenzothiazole-derived semicarbazones.
Tripathi RK; Goshain O; Ayyannan SR
ChemMedChem; 2013 Mar; 8(3):462-74. PubMed ID: 23325700
[TBL] [Abstract][Full Text] [Related]
33. Selective inhibition of monoamine oxidase A by chelerythrine, an isoquinoline alkaloid.
Baek SC; Ryu HW; Kang MG; Lee H; Park D; Cho ML; Oh SR; Kim H
Bioorg Med Chem Lett; 2018 Aug; 28(14):2403-2407. PubMed ID: 29925480
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
[TBL] [Abstract][Full Text] [Related]
35. Design and discovery of anthranilamide derivatives as a potential treatment for neurodegenerative disorders via targeting cholinesterases and monoamine oxidases.
Zaib S; Khan I; Ali HS; Younas MT; Ibrar A; Al-Odayni AB; Al-Kahtani AA
Int J Biol Macromol; 2024 Jun; 272(Pt 1):132748. PubMed ID: 38821306
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and structure-activity relationship study of novel 3-heteroarylcoumarins based on pyridazine scaffold as selective MAO-B inhibitors.
Costas-Lago MC; Besada P; Rodríguez-Enríquez F; Viña D; Vilar S; Uriarte E; Borges F; Terán C
Eur J Med Chem; 2017 Oct; 139():1-11. PubMed ID: 28797881
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of monoamine oxidase by benzoxathiolone analogues.
Mostert S; Petzer A; Petzer JP
Bioorg Med Chem Lett; 2016 Feb; 26(4):1200-4. PubMed ID: 26821818
[TBL] [Abstract][Full Text] [Related]
38. (Hetero-)(arylidene)arylhydrazides as Multitarget-Directed Monoamine Oxidase Inhibitors.
Palakkathondi A; Oh JM; Dev S; Rangarajan TM; Kaipakasseri S; Kavully FS; Gambacorta N; Nicolotti O; Kim H; Mathew B
ACS Comb Sci; 2020 Nov; 22(11):592-599. PubMed ID: 33047950
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of quinazoline amino acid derivatives as mono amine oxidase (MAO) inhibitors.
Khattab SN; Haiba NS; Asal AM; Bekhit AA; Amer A; Abdel-Rahman HM; El-Faham A
Bioorg Med Chem; 2015 Jul; 23(13):3574-85. PubMed ID: 25922182
[TBL] [Abstract][Full Text] [Related]
40. Design, Synthesis and Biological Evaluation of Novel N-Pyridyl-Hydrazone Derivatives as Potential Monoamine Oxidase (MAO) Inhibitors.
Turan-Zitouni G; Hussein W; Sağlık BN; Tabbi A; Korkut B
Molecules; 2018 Jan; 23(1):. PubMed ID: 29316677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
